However, as the clinical parameters in the mice lacking mMCP-4 were not significantly different from the mMCP-4-competent mice, our result suggests that the regulation of the IL-33 levels by chymase is not a driving factor in the current AD-model. Here, CMA1 is linked to Alzheimer disease.